Stay updated on Daratumumab for Mobilization and ASCT in Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab for Mobilization and ASCT in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab for Mobilization and ASCT in Myeloma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-10-31T12:16:20.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A notice above the study record links to NIH updates and FAQs and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition.
    Difference
    0.7%
    Check dated 2026-10-24T12:01:25.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision marker in the footer changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T12:34:15.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T12:48:51.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry (v3.7.0) representing an update to the study record; the prior revision v3.6.6 was removed from the current history.
    Difference
    0.1%
    Check dated 2026-09-19T18:47:43.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.6.6 was added to the study record history, while the previous v3.6.5 entry was removed.
    Difference
    0.1%
    Check dated 2026-08-29T19:59:31.000Z thumbnail image

Stay in the know with updates to Daratumumab for Mobilization and ASCT in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab for Mobilization and ASCT in Myeloma Clinical Trial page.